Objective To explore the protective effect of AVE0991,a non-peptide Ang( 1-7) receptor agonist,on rat models of diabetic nephropathy. Methods A total of 30 male Wistar rats were randomly divided into 3 groups: normal control group( NC group,n = 10),streptozotocin( STZ) induced diabetic nephropathy group( DN group,n = 10) and AVE0991 treatment group( AVE group,n = 10). After the DN group and AVE group received intraperitoneal injection of streptozotocin( STZ) 65 mg / kg for 8 weeks,the AVE group received AVE...